Detail akcie Perrigo online

Business Summary: Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. It primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.
Financial Summary: BRIEF: For the six months ended 29 June 2024, Perrigo Company PLC revenues decreased 10% to $2.15B. Net loss before extraordinary items totaled $101.6M vs. income of $7.8M. Revenues reflect CSCA segment decrease of 16% to $1.28B, United States segment decrease of 15% to $1.26B, Europe segment decrease of 1% to $828.1M. Net loss reflects CSCA segment income decrease of 53% to $85M, Unallocated segment loss increase of 73% to $182.9M.